IL15 and neoplasm: In brief, the shift from a Th1 to a Th2 inflammatory response will lead to an increase in immunosuppressive cytokine release (IL-2, IL-4, IL-7, IL-13, and IL-15) by neoplastic elements and tumor-associated cells, sustaining tumor growth and spread.